175 related articles for article (PubMed ID: 37480114)
1. Lipopolysaccharide-binding protein and future Parkinson's disease risk: a European prospective cohort.
Zhao Y; Walker DI; Lill CM; Bloem BR; Darweesh SKL; Pinto-Pacheco B; McNeil B; Miller GW; Heath AK; Frissen M; Petrova D; Sánchez MJ; Chirlaque MD; Guevara M; Zibetti M; Panico S; Middleton L; Katzke V; Kaaks R; Riboli E; Masala G; Sieri S; Zamora-Ros R; Amiano P; Jenab M; Peters S; Vermeulen R
J Neuroinflammation; 2023 Jul; 20(1):170. PubMed ID: 37480114
[TBL] [Abstract][Full Text] [Related]
2. Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson's Disease.
Chen SJ; Chi YC; Ho CH; Yang WS; Lin CH
J Parkinsons Dis; 2021; 11(3):1129-1139. PubMed ID: 33720853
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipopolysaccharide-binding protein and colorectal cancer risk: a nested case-control study in the Multiethnic Cohort.
Citronberg JS; Wilkens LR; Le Marchand L; Lim U; Monroe KR; Hullar MAJ; White E; Newcomb PA; Lampe JW
Cancer Causes Control; 2018 Jan; 29(1):115-123. PubMed ID: 29189972
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-Binding Protein, Soluble CD14, and the Long-Term Risk of Alzheimer's Disease: A Nested Case-Control Pilot Study of Older Community Dwellers from the Three-City Cohort.
André P; Samieri C; Buisson C; Dartigues JF; Helmer C; Laugerette F; Féart C
J Alzheimers Dis; 2019; 71(3):751-761. PubMed ID: 31450497
[TBL] [Abstract][Full Text] [Related]
5. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
[TBL] [Abstract][Full Text] [Related]
6. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.
Sun L; Yu Z; Ye X; Zou S; Li H; Yu D; Wu H; Chen Y; Dore J; Clément K; Hu FB; Lin X
Diabetes Care; 2010 Sep; 33(9):1925-32. PubMed ID: 20530747
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
[TBL] [Abstract][Full Text] [Related]
8. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial.
Vors C; Pineau G; Drai J; Meugnier E; Pesenti S; Laville M; Laugerette F; Malpuech-Brugère C; Vidal H; Michalski MC
J Clin Endocrinol Metab; 2015 Sep; 100(9):3427-35. PubMed ID: 26151336
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of LPS-binding protein in bovine blood and milk following bacterial lipopolysaccharide challenge.
Bannerman DD; Paape MJ; Hare WR; Sohn EJ
J Dairy Sci; 2003 Oct; 86(10):3128-37. PubMed ID: 14594231
[TBL] [Abstract][Full Text] [Related]
10. Serum lipopolysaccharide-binding protein levels and cardiovascular events in hemodialysis patients: A prospective cohort study.
Lin TY; Chang YK; Wu MY; Wu TK; Chen CH; Lim PS
Nephrology (Carlton); 2022 Nov; 27(11):877-885. PubMed ID: 36045565
[TBL] [Abstract][Full Text] [Related]
11. Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease.
Pal GD; Shaikh M; Forsyth CB; Ouyang B; Keshavarzian A; Shannon KM
Front Neurosci; 2015; 9():306. PubMed ID: 26388718
[TBL] [Abstract][Full Text] [Related]
12. Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.
Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
PLoS Med; 2022 Sep; 19(9):e1004092. PubMed ID: 36107840
[TBL] [Abstract][Full Text] [Related]
13. Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
Zhao Y; Lai Y; Konijnenberg H; Huerta JM; Vinagre-Aragon A; Sabin JA; Hansen J; Petrova D; Sacerdote C; Zamora-Ros R; Pala V; Heath AK; Panico S; Guevara M; Masala G; Lill CM; Miller GW; Peters S; Vermeulen R
Neurology; 2024 Apr; 102(8):e209201. PubMed ID: 38513162
[TBL] [Abstract][Full Text] [Related]
14. LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction.
Minter RM; Bi X; Ben-Josef G; Wang T; Hu B; Arbabi S; Hemmila MR; Wang SC; Remick DG; Su GL
Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G45-54. PubMed ID: 18948440
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.
Sakura T; Morioka T; Shioi A; Kakutani Y; Miki Y; Yamazaki Y; Motoyama K; Mori K; Fukumoto S; Shoji T; Emoto M; Inaba M
Cardiovasc Diabetol; 2017 May; 16(1):62. PubMed ID: 28486964
[TBL] [Abstract][Full Text] [Related]
16. Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study in northwest of Iran.
Saghafi-Asl M; Amiri P; Naghizadeh M; Ghavami SM; Karamzad N
BMJ Open; 2017 May; 7(5):e015910. PubMed ID: 28487462
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum lipopolysaccharide binding protein levels, disease activity, and clinical characteristics in Paraguayan patients with systemic lupus erythematosus.
Losanto J; Langjahr P; Barrios G; Paats A; Acosta de Hetter ME; de Guillén I; Duarte M; Acosta-Colman I; Cervera R
Lupus; 2021 Nov; 30(13):2089-2094. PubMed ID: 34693812
[TBL] [Abstract][Full Text] [Related]
18. Serum lipopolysaccharide-binding protein concentrations in trauma victims.
Cunningham SC; Malone DL; Bochicchio GV; Genuit T; Keledjian K; Tracy JK; Napolitano LM
Surg Infect (Larchmt); 2006 Jun; 7(3):251-61. PubMed ID: 16875458
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity.
Kheirandish-Gozal L; Peris E; Wang Y; Tamae Kakazu M; Khalyfa A; Carreras A; Gozal D
J Clin Endocrinol Metab; 2014 Feb; 99(2):656-63. PubMed ID: 24276451
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
Pretorius E; Page MJ; Mbotwe S; Kell DB
PLoS One; 2018; 13(3):e0192121. PubMed ID: 29494603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
